Experience with Octreotide in patients with castration refractory prostate cancer

被引：0
|
作者：
Ganov, D. I. [1 ]
Varlamov, S. A. [1 ]
机构：
[1] Altai State Med Univ, Kussian Acad Med Sci, NN Blokhin Russian Canc Res Ctr, Altai Branch, Barnaul, Russia
来源：
ONKOUROLOGIYA | 2011年 / 7卷 / 04期
关键词：
castration refractory prostate cancer; sustained-release octreotide;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Fifteen patients with castration refractory prostate cancer have been treated with sustained-release octreotide in combination with dexamethasone at the Altai Territory Oncology Dispensary since 2008. Control PSA test revealed that 9 (60 %) patients had positive changes; tumor process stabilization was noted in 4 (26.7 %) and only 2 (13.3 %) were found to have disease progression. Thus, more than 86 % of patients responded to combination treatment with sustained-release octreotide + dexamethasone. Octreotide treatment caused no serious specific adverse toxic reactions.
引用
收藏
页码：71 / 73
页数：3
相关论文
共 50 条
  • [41] Report on an International Conference on the diagnosis and treatment of castration-refractory prostate cancer
    Nyushko, K. M.
    ONKOUROLOGIYA, 2014, 10 (01): : 91 - 93
  • [42] Enzalutamide for Patients with castration-resistant Prostate Cancer
    Kessing, Richard
    AKTUELLE UROLOGIE, 2020, 51 (01)
  • [43] Surgical versus medical castration in prostate cancer patients
    Nature Clinical Practice Urology, 2005, 2 (1): : 4 - 4
  • [44] Surgical versus medical castration in prostate cancer patients
    Nature Clinical Practice Oncology, 2005, 2 (1): : 9 - 10
  • [45] Second line chemotherapy in patients with castration-refractory prostate cancer. From clinical studies to practice
    Alekseev, B. Ya
    Nyushko, K. M.
    Kaprin, A. D.
    ONKOUROLOGIYA, 2019, 15 (01): : 84 - 91
  • [46] Cabazitaxel in patients with castration-resistant prostate cancer
    Falcao, Gil
    Carneiro, Cabrita
    Pinheiro, Luis Campos
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 : 25 - 25
  • [47] Management of the Side Effects of Androgenic Suppression by Castration in Prostate Cancer: The Ivorian Experience Side Effects of Castration in Prostate Cancer in Cote d'Ivoire
    Kouassi, K. K. Y.
    Odo, B. A.
    Nzamba, B. P. L.
    Toure, P. L.
    Nziengui, T. C.
    Mebiala, P.
    Toure, M.
    PSYCHO-ONCOLOGIE, 2021, 15 (1-2) : 35 - 37
  • [48] The Experience with Cytotoxic Chemotherapy in Metastatic Castration-Resistant Prostate Cancer
    Eisenberger, Mario A.
    Antonarakis, Emmanuel S.
    UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : 573 - +
  • [49] Diethylstilbestrol for the treatment of patients with castration-resistant prostate cancer: Retrospective analysis of a single institution experience
    Grenader, Tal
    Plotkin, Yevgeni
    Gips, Maya
    Cherny, Nathan
    Gabizon, Alberto
    ONCOLOGY REPORTS, 2014, 31 (01) : 428 - 434
  • [50] Alternative antiandrogen therapy in patients with castration-resistant prostate cancer: A single-center experience
    Okegawa, Takatsugu
    Nutahara, Kikuo
    Higashihara, Eiji
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 (11) : 950 - 955
12345